Literature DB >> 3034272

Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide.

S Kitagawa, A Yuo, L M Souza, M Saito, Y Miura, F Takaku.   

Abstract

Recombinant human granulocyte colony-stimulating factor (G-CSF) by itself was not an effective stimulus for inducing the release of superoxide (O-2) in human granulocytes. However, G-CSF was able to prime human granulocytes, and enhanced O-2 release stimulated by the chemotactic peptide, N-formyl-methionyl-leucyl-phenylalanine (FMLP). The preincubation with G-CSF for 5-10 min at 37 degrees C was sufficient for priming the cells. The optimal enhancing effect was obtained at 25 ng/ml of G-CSF. The enhancement of O-2 release by G-CSF was observed over the complete range of effective concentrations of FMLP (10(-8)-10(-6) M). These findings indicate that G-CSF is a potent activator of mature granulocyte functions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034272     DOI: 10.1016/0006-291x(87)91430-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

Review 1.  Healing the diabetic wound and keeping it healed: modalities for the early 21st century.

Authors:  Matthew J Claxton; David G Armstrong; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

2.  Haemopoietic growth factors: their role in cell development and their clinical use.

Authors:  N G Testa; T M Dexter
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

3.  Suppression of polymorphonuclear leukocyte bactericidal activity by suramin.

Authors:  E Roilides; P Paschalides; A Freifeld; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.

Authors:  K Shimoda; S Okamura; N Harada; S Kondo; T Okamura; Y Niho
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.

Authors:  H Wakiyama; S Tsuru; N Hata; M Shinomiya; N Shinomiya; M Noritake; Y Umezawa; M Rokutanda
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

6.  Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.

Authors:  E Roilides; K Uhlig; D Venzon; P A Pizzo; T J Walsh
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor.

Authors:  K Anding; A Kropec; E Schmidt-Eisenlohr; A Benzing; K Geiger; F Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

8.  Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis.

Authors:  M Katano; M Nakamura; T Matsuo; A Iyama; T Hisatsugu
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  The granulocyte colony-stimulating factor produced in the human lung and its effect on liquid movement in the rabbit lung.

Authors:  T Sakuma; T Nakada; T Nishimura; Y Hoshikawa; S Fujimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  Association between elevated plasma granulocyte colony-stimulating factor and the degree of surgical stress in patients undergoing gastrointestinal surgery.

Authors:  K Yokota; T Nishihira; R Shineha; J Sayama; Y Nitta; M Kimura; S Mori
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.